Abbott Laboratories 2012 Annual Report Download - page 32

Download and view the complete annual report

Please find page 32 of the 2012 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

30
Abbott 2012 Annual Report
Year Ended December31 2012 2011 2010
Common Shares:
Beginning of Year
Shares: 2012: 1,638,870,201; 2011: 1,619,689,876; 2010: 1,612,683,987 $ 9,817,134 $ 8,744,703 $ 8,257,873
Issued under incentive stock programs
Shares: 2012: 37,060,283; 2011: 19,180,325; 2010: 7,005,889 1,853,574 954,148 316,071
Share-based compensation 434,601 382,326 388,493
Issuance of restricted stock awards (350,757) (264,043) (217,734)
End of Year
Shares: 2012: 1,675,930,484; 2011: 1,638,870,201; 2010: 1,619,689,876 $11,754,552 $ 9,817,134 $ 8,744,703
Common Shares Held in Treasury:
Beginning of Year
Shares: 2012: 68,491,382; 2011: 72,705,928; 2010: 61,516,398 $ (3,687,478) $ (3,916,823) $ (3,310,347)
Issued under incentive stock programs
Shares: 2012: 6,691,748; 2011: 4,638,841; 2010: 4,166,200 362,764 249,876 224,237
Purchased
Shares: 2012: 37,463,358; 2011: 424,295; 2010: 15,355,730 (2,266,195) (20,531) (830,713)
End of Year
Shares: 2012: 99,262,992; 2011: 68,491,382; 2010: 72,705,928 $ (5,590,909) $ (3,687,478) $ (3,916,823)
Earnings Employed in the Business:
Beginning of Year $20,907,362 $19,215,768 $17,342,694
Net earnings 5,962,920 4,728,449 4,626,172
Cash dividends declared on common shares
(per share— 2012: $1.67; 2011: $1.92; 2010: $1.76) (2,649,866) (3,011,631) (2,731,584)
Effect of common and treasury share transactions (69,420) (25,224) (21,514)
End of Year $24,150,996 $20,907,362 $19,215,768
Accumulated Other Comprehensive Income (Loss):
Beginning of Year $ (2,597,185) $ (1,366,846) $ 854,074
Other comprehensive income (loss) (996,493) (1,230,339) (2,220,920)
End of Year $ (3,593,678) $ (2,597,185) $ (1,366,846)
Noncontrolling Interests in Subsidiaries:
Beginning of Year $ 86,312 $ 88,329 $ 43,102
Noncontrolling Interests’ share of income,
business combinations, net of distributions and share repurchases 5,959 (2,017) 45,227
End of Year $ 92,271 $ 86,312 $ 88,329
The accompanying notes to consolidated financial statements are an integral part of this statement.
Consolidated Statement of Shareholders’ Investment
(dollars in thousands except per share data)